Global Orphan Drugs Market Research Report 2019

Table of Contents

Executive Summary

1 Orphan Drugs Market Overview

• 1.1 Product Overview and Scope of Orphan Drugs
• 1.2 Orphan Drugs Segment by Type
  • 1.2.1 Global Orphan Drugs Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Oncology
  • 1.2.3 Gastrointestinal
  • 1.2.4 Pulmonary
  • 1.2.5 Neurology
  • 1.2.6 Hematology
  • 1.2.7 Cardio-vascular
  • 1.2.8 Metabolic disorders
  • 1.2.9 Endocrinology
  • 1.2.10 Infectious diseases
  • 1.2.11 Others
• 1.3 Orphan Drugs Segment by Application
  • 1.3.1 Orphan Drugs Consumption Comparison by Application (2014-2025)
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Speciality Pharmacies
  • 1.3.4 Retail pharmacies
  • 1.3.5 Others
• 1.4 Global Orphan Drugs Market by Region
  • 1.4.1 Global Orphan Drugs Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Orphan Drugs Market Size
  • 1.5.1 Global Orphan Drugs Revenue (2014-2025)
  • 1.5.2 Global Orphan Drugs Production (2014-2025)

2 Global Orphan Drugs Market Competition by Manufacturers

• 2.1 Global Orphan Drugs Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Orphan Drugs Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Orphan Drugs Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Orphan Drugs Production Sites, Area Served, Product Types
• 2.5 Orphan Drugs Market Competitive Situation and Trends
  • 2.5.1 Orphan Drugs Market Concentration Rate
  • 2.5.2 Orphan Drugs Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Orphan Drugs Production Market Share by Regions

• 3.1 Global Orphan Drugs Production Market Share by Regions
• 3.2 Global Orphan Drugs Revenue Market Share by Regions (2014-2019)
• 3.3 Global Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Orphan Drugs Production
  • 3.4.1 North America Orphan Drugs Production Growth Rate (2014-2019)
  • 3.4.2 North America Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Orphan Drugs Production
  • 3.5.1 Europe Orphan Drugs Production Growth Rate (2014-2019)
  • 3.5.2 Europe Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Orphan Drugs Production (2014-2019)
  • 3.6.1 China Orphan Drugs Production Growth Rate (2014-2019)
  • 3.6.2 China Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Orphan Drugs Production (2014-2019)
  • 3.7.1 Japan Orphan Drugs Production Growth Rate (2014-2019)
  • 3.7.2 Japan Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Orphan Drugs Consumption by Regions

• 4.1 Global Orphan Drugs Consumption by Regions
• 4.2 North America Orphan Drugs Consumption (2014-2019)
• 4.3 Europe Orphan Drugs Consumption (2014-2019)
• 4.4 China Orphan Drugs Consumption (2014-2019)
• 4.5 Japan Orphan Drugs Consumption (2014-2019)

5 Global Orphan Drugs Production, Revenue, Price Trend by Type

• 5.1 Global Orphan Drugs Production Market Share by Type (2014-2019)
• 5.2 Global Orphan Drugs Revenue Market Share by Type (2014-2019)
• 5.3 Global Orphan Drugs Price by Type (2014-2019)
• 5.4 Global Orphan Drugs Production Growth by Type (2014-2019)

6 Global Orphan Drugs Market Analysis by Applications

• 6.1 Global Orphan Drugs Consumption Market Share by Application (2014-2019)
• 6.2 Global Orphan Drugs Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Orphan Drugs Business

• 7.1 Novartis
  • 7.1.1 Novartis Orphan Drugs Production Sites and Area Served
  • 7.1.2 Orphan Drugs Product Introduction, Application and Specification
  • 7.1.3 Novartis Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Bristol-Myers Squibb
  • 7.2.1 Bristol-Myers Squibb Orphan Drugs Production Sites and Area Served
  • 7.2.2 Orphan Drugs Product Introduction, Application and Specification
  • 7.2.3 Bristol-Myers Squibb Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Celgene
  • 7.3.1 Celgene Orphan Drugs Production Sites and Area Served
  • 7.3.2 Orphan Drugs Product Introduction, Application and Specification
  • 7.3.3 Celgene Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Roche
  • 7.4.1 Roche Orphan Drugs Production Sites and Area Served
  • 7.4.2 Orphan Drugs Product Introduction, Application and Specification
  • 7.4.3 Roche Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Pfizer
  • 7.5.1 Pfizer Orphan Drugs Production Sites and Area Served
  • 7.5.2 Orphan Drugs Product Introduction, Application and Specification
  • 7.5.3 Pfizer Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Sanofi
  • 7.6.1 Sanofi Orphan Drugs Production Sites and Area Served
  • 7.6.2 Orphan Drugs Product Introduction, Application and Specification
  • 7.6.3 Sanofi Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Alexion Pharmaceuticals
  • 7.7.1 Alexion Pharmaceuticals Orphan Drugs Production Sites and Area Served
  • 7.7.2 Orphan Drugs Product Introduction, Application and Specification
  • 7.7.3 Alexion Pharmaceuticals Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Eli Lilly
  • 7.8.1 Eli Lilly Orphan Drugs Production Sites and Area Served
  • 7.8.2 Orphan Drugs Product Introduction, Application and Specification
  • 7.8.3 Eli Lilly Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Novo Nordisk
  • 7.9.1 Novo Nordisk Orphan Drugs Production Sites and Area Served
  • 7.9.2 Orphan Drugs Product Introduction, Application and Specification
  • 7.9.3 Novo Nordisk Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 AstraZeneca
  • 7.10.1 AstraZeneca Orphan Drugs Production Sites and Area Served
  • 7.10.2 Orphan Drugs Product Introduction, Application and Specification
  • 7.10.3 AstraZeneca Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Eisai
• 7.12 Daiichi Sankyo
• 7.13 Bayer
• 7.14 GlaxoSmithKline
• 7.15 Merck
• 7.16 Johnson & Johnson
• 7.17 Biogen
• 7.18 Shire
• 7.19 Amgen

8 Orphan Drugs Manufacturing Cost Analysis

• 8.1 Orphan Drugs Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Orphan Drugs
• 8.4 Orphan Drugs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Orphan Drugs Distributors List
• 9.3 Orphan Drugs Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Orphan Drugs Market Forecast

• 11.1 Global Orphan Drugs Production, Revenue Forecast
  • 11.1.1 Global Orphan Drugs Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Orphan Drugs Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Orphan Drugs Price and Trend Forecast (2019-2025)
• 11.2 Global Orphan Drugs Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Orphan Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Orphan Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Orphan Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Orphan Drugs Production, Revenue Forecast (2019-2025)
• 11.3 Global Orphan Drugs Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Orphan Drugs Consumption Forecast (2019-2025)
  • 11.3.2 Europe Orphan Drugs Consumption Forecast (2019-2025)
  • 11.3.3 China Orphan Drugs Consumption Forecast (2019-2025)
  • 11.3.4 Japan Orphan Drugs Consumption Forecast (2019-2025)
• 11.4 Global Orphan Drugs Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Orphan Drugs Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List